Clinical Trial: IASO206 in Patients With Relapsed/Refractory Multiple Myeloma

U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07322159) titled 'IASO206 in Patients With Relapsed/Refractory Multiple Myeloma' on Dec. 09, 2025.

Brief Summary: This study is an open-label, single-arm early exploratory clinical study, aiming to evaluate the safety, tolerability and preliminary efficacy of IASO206 Injection(In Vivo CAR-T) in Patients with Relapsed/Refractory Multiple Myeloma

Study Start Date: Jan. 15

Study Type: INTERVENTIONAL

Condition: Relapsed/Refractory Multiple Myeloma (RRMM)

Intervention: DRUG: IASO206 injection

The third-generation self-inactivating lentiviral vector that carries a BCMA-targeted CAR.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Institute of Hemat...